CSNK2A1 is involved in cancer progression by regulating various cancer-promoting signaling pathways, such as the MYC, PI3K-Akt, NFκB, and Wnt/β-catenin pathways [3,10,11,12,13,14]. This evidence concerns the gene AKT1 and cancer.